← Back to Clinical Trials
Recruiting NCT04005638

NCT04005638 Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04005638
Status Recruiting
Phase
Sponsor University Hospital, Bordeaux
Condition Immune Thrombocytopenia
Study Type OBSERVATIONAL
Enrollment 200 participants
Start Date 2019-02-02
Primary Completion 2027-01

Trial Parameters

Condition Immune Thrombocytopenia
Sponsor University Hospital, Bordeaux
Study Type OBSERVATIONAL
Phase N/A
Enrollment 200
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2019-02-02
Completion 2027-01
Interventions
blood sampleurine sample

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The Internal Medicine Department of Haut-Lévêque Hospital (Pr E LAZARO, Pr JL PELLEGRIN, Pr JF VIALLARD) was accredited in 2017 by the Ministry of Health as a Constitutive Reference Center for Autoimmune Cytopenia. The investigators wish to launch new research projects in autoimmune cytopenia and propose a translational and fundamental research based on collaboration between the clinical department, the biological resource center and the CNRS and INSERM research units ("Bedside to the Bench Strategy"). Thus, in the perspective of future research work, it seems imperative to set up a biological bank for the patients followed in our Reference Center.

Eligibility Criteria

Inclusion Criteria: * Patients over 16 years old. * Patients with autoimmune cytopenia according to the definitions reported in the latest update of the French National Care Protocol (PNDS 2017). * Affiliated person or beneficiary of a social security scheme. * Free, informed and written consent signed by the participant and the investigator (at the latest on the day of inclusion and before any examination required by the research). Exclusion Criteria: * Positivity for HIV, Hepatitis C or B virus. * Pregnant or lactating woman. * Patient undergoing treatment for autoimmune cytopenia

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology